Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies
Abstract Background Malignant glioma cell line models are integral to pre-clinical testing of novel potential therapies. Accurate prediction of likely efficacy in the clinic requires that these models are reliable and consistent. We assessed this by examining the reporting of experimental conditions...
Guardado en:
Autores principales: | Michael T. C. Poon, Morgan Bruce, Joanne E. Simpson, Cathal J. Hannan, Paul M. Brennan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da02e9ee3efb494ea3436c9175d4c261 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM)
por: Sinning,Mariana, et al.
Publicado: (2012) -
Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres
por: Martina Giambra, et al.
Publicado: (2021) -
Suppression of Ribosome Biogenesis by Targeting WD Repeat Domain 12 (WDR12) Inhibits Glioma Stem-Like Cell Growth
por: Lanjuan Mi, et al.
Publicado: (2021) -
Glioma multifocal multicéntrico
por: Guerrero T,Rodrigo, et al.
Publicado: (2010) -
Cytotoxicity induced by carbon nanotubes in experimental malignant glioma
por: Romano-Feinholz S, et al.
Publicado: (2017)